Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4N40

Crystal structure of human Epithelial cell-transforming sequence 2 protein

Summary for 4N40
Entry DOI10.2210/pdb4n40/pdb
DescriptorProtein ECT2 (1 entity in total)
Functional Keywordstriple brct domains, cell cycle
Biological sourceHomo sapiens (human)
Cellular locationNucleus: Q9H8V3
Total number of polymer chains1
Total formula weight33073.29
Authors
Zou, Y.,Shao, Z.H.,Li, F.D.,Gong, D.,Wang, C.,Gong, Q.,Shi, Y. (deposition date: 2013-10-08, release date: 2014-08-27, Last modification date: 2024-10-09)
Primary citationZou, Y.,Shao, Z.H.,Peng, J.,Li, F.D.,Gong, D.,Wang, C.,Zuo, X.,Zhang, Z.,Wu, J.,Shi, Y.,Gong, Q.
Crystal structure of triple-BRCT-domain of ECT2 and insights into the binding characteristics to CYK-4
Febs Lett., 588:2911-2920, 2014
Cited by
PubMed Abstract: Homo sapiens ECT2 is a cell cycle regulator that plays critical roles in cytokinesis. ECT2 activity is restrained during interphase via intra-molecular interactions that involve its N-terminal triple-BRCT-domain and its C-terminal DH-PH domain. At anaphase, this self-inhibitory mechanism is relieved by Plk1-phosphorylated CYK-4, which directly engages the ECT2 BRCT domain. To provide a structural perspective for this auto-inhibitory property, we solved the crystal structure of the ECT2 triple-BRCT-domain. In addition, we systematically analyzed the interaction between the ECT2 BRCT domains with phospho-peptides derived from its binding partner CYK-4, and have identified Ser164 as the major phospho-residue that links CYK-4 to the second ECT2 BRCT domain.
PubMed: 25068414
DOI: 10.1016/j.febslet.2014.07.019
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.106 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon